Impact of combined hormonal contraceptives and metformin on metabolic syndrome in women with hyperandrogenic polycystic ovary syndrome and obesity: The COMET-PCOS randomized clinical trial.
<h4>Background</h4>The risk-to-benefit ratio of using combined oral contraceptive pills (COCPs) and/or metformin for comprehensive management of polycystic ovary syndrome (PCOS) in women with obesity is unclear. As there is a lack of robust evidence on the impact of these first-line medications on c...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2025-12-01
|
| Col·lecció: | PLoS Medicine |
| Accés en línia: | https://doi.org/10.1371/journal.pmed.1004662 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|